Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Nieforth

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Pharmacology|November 15, 2003
Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtideMark Alastair Boyd, Xiaoping Zhang, Albert Dorr, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 28, 2024
pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimizationXinnong Li, Mark Sale, Keith Nieforth, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 16, 2024
RPEM: Randomized Monte Carlo parametric expectation maximization algorithmRong Chen, Alan Schumitzky, Alona Kryshchenko, et al.
Clinical Pharmacology and Therapeutics|December 1, 2023
pyDarwin: A Machine Learning Enhanced Automated Nonlinear Mixed-Effect Model Selection ToolboxXinnong Li, Mark Sale, Keith Nieforth, et al.
Clinical Pharmacology and Therapeutics|August 2, 2002
Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment dispositionXiaoping Zhang, Keith Nieforth, Jean-Marie Lang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 17, 2016
Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjectsPeter N Morcos, Li Yu, Katrijn Bogman, et al.
British Journal of Clinical Pharmacology|February 9, 2017
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemicsMohamed A Kamal, Patrick F Smith, Nathorn Chaiyakunapruk, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Pharmacology|November 15, 2003
Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtideMark Alastair Boyd, Xiaoping Zhang, Albert Dorr, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 28, 2024
pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimizationXinnong Li, Mark Sale, Keith Nieforth, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 16, 2024
RPEM: Randomized Monte Carlo parametric expectation maximization algorithmRong Chen, Alan Schumitzky, Alona Kryshchenko, et al.
Clinical Pharmacology and Therapeutics|December 1, 2023
pyDarwin: A Machine Learning Enhanced Automated Nonlinear Mixed-Effect Model Selection ToolboxXinnong Li, Mark Sale, Keith Nieforth, et al.
Clinical Pharmacology and Therapeutics|August 2, 2002
Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment dispositionXiaoping Zhang, Keith Nieforth, Jean-Marie Lang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 17, 2016
Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjectsPeter N Morcos, Li Yu, Katrijn Bogman, et al.
British Journal of Clinical Pharmacology|February 9, 2017
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemicsMohamed A Kamal, Patrick F Smith, Nathorn Chaiyakunapruk, et al.
Pageof 2